Metabolic tumor volume predicts overall survival in lung cancer patients treated definitively

被引：0
|
作者：
Lee, P. [1 ]
Bazan, J. G. [1 ]
Weerasuriya, D. K. [1 ]
Lavori, P. W. [2 ]
Quon, A. [3 ]
Le, Q. [1 ]
Loo, B. W., Jr. [1 ]
机构：
[1] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[3] Stanford Univ, Div Nucl Med, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2008.06.1375
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S462 / S462
页数：1
相关论文
共 50 条
  • [21] Impact of tumor mutational burden on overall survival in patients with non-small cell lung cancer treated with immunotherapy
    Awad, Mark
    Mahadevan, Navin
    Polio, Andrew
    Vokes, Natalie
    Aguilar, Elizabeth
    Ricciuti, Biagio
    Lamberti, Giuseppe
    Recondo, Gonzalo
    Leonardi, Giulia
    Adeni, Anika
    Janne, Pasi
    Van Allen, Eliezer
    Albayrak, Adem
    Umeton, Renato
    Sholl, Lynette
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [22] Tumor Time-Course Predicts Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow-Up Time
    Netterberg, Ida
    Bruno, Rene
    Chen, Ya-Chi
    Winter, Helen
    Li, Chi-Chung
    Jin, Jin Y.
    Friberg, Lena E.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (02): : 115 - 123
  • [23] Higher pretreatment lactate dehydrogenase concentration predicts worse overall survival in patients with lung cancer
    Deng, Taibing
    Zhang, Jing
    Meng, Yu
    Zhou, Yongzhao
    Li, Weimin
    MEDICINE, 2018, 97 (38)
  • [24] A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma
    Wu, Jie
    Li, Lan
    Zhang, Huibo
    Zhao, Yaqi
    Zhang, Haohan
    Wu, Siyi
    Xu, Bin
    ONCOGENE, 2021, 40 (26) : 4413 - 4424
  • [25] A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma
    Jie Wu
    Lan Li
    Huibo Zhang
    Yaqi Zhao
    Haohan Zhang
    Siyi Wu
    Bin Xu
    Oncogene, 2021, 40 : 4413 - 4424
  • [26] Metabolic Tumor Volume Is Superior to Gross Tumor Volume in Predicting Outcomes in Patients With Oropharyngeal Cancer Treated With IMRT
    Romesser, P.
    Riaz, N.
    Lok, B. H.
    Setton, J.
    Rao, S.
    Lee, N. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S474 - S474
  • [27] Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab
    Halvorsen, Ann Rita
    Sandhu, Vandana
    Sprauten, Mette
    Flote, Vidar G.
    Kure, Elin H.
    Brustugun, Odd Terje
    Helland, Aslaug
    ACTA ONCOLOGICA, 2018, 57 (09) : 1225 - 1231
  • [28] Conditional Survival of Surgically Treated Patients with Lung Cancer: A of Overall, Recurrence-Free, and Relative Survival
    Shin, Dong Wook
    Cho, Jong Ho
    Yoo, Jung Eun
    Cho, Juhee
    Yoon, Dong Woog
    Lee, Genehee
    Shin, Sumin
    Kim, Hong Kwan
    Choi, Yong Soo
    Kim, Jhingook
    Zo, Jae, III
    Shim, Young Mog
    CANCER RESEARCH AND TREATMENT, 2021, 53 (04): : 1057 - 1071
  • [29] DELTA-RADIOMICS PREDICTS RESPONSE AND OVERALL SURVIVAL IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH DURVALUMAB
    Khorrami, Mohammadhadi
    Viswanathan, Vidya Sankar
    Gupta, Amit
    Li, Qin
    Gupta, Ashok
    Achour, Ikbel
    Fitzgerald, Brian
    Velcheti, Vamsidhar
    Madabhushi, Anant
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A79 - A79
  • [30] Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer
    Sun, Gaofeng
    Cheng, Chao
    Li, Xiao
    Wang, Tao
    Yang, Jian
    Li, Danni
    CANCER IMAGING, 2019, 19 (1)
12345